HIV and Solid Organ Transplantation: Where Are we Now

被引:23
|
作者
Botha, Jean [1 ]
Fabian, June [1 ]
Etheredge, Harriet [1 ]
Conradie, Francesca [2 ]
Tiemessen, Caroline T. [3 ,4 ]
机构
[1] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Wits Donald Gordon Med Ctr,Dept Internal Med, 7 York Rd, ZA-2193 Johannesburg, South Africa
[2] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Clin HIV Res Unit, 7 York Rd, ZA-2193 Johannesburg, South Africa
[3] Natl Inst Communicable Dis, Ctr HIV & STIs, 1 Modderfontein Rd,2131 Private Bag X4, ZA-2131 Johannesburg, South Africa
[4] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, 7 York Rd, ZA-2193 Johannesburg, South Africa
关键词
Solid organ transplantation; HIV; South Africa; Living donor; HIV-positive-to-HIV-negative; Antiretroviral therapy; HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; KIDNEY-TRANSPLANTATION; RENAL-TRANSPLANTATION; PEANUT ALLERGY; ANTIRETROVIRAL THERAPY; NEGATIVE RECIPIENTS; SEROLOGIC RESPONSES; LIVER-TRANSPLANT; POSITIVE MOTHER;
D O I
10.1007/s11904-019-00460-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of Review We review the international evolution of HIV and solid organ transplantation over 30 years. We emphasise recent developments in solid organ transplantation from HIV-infected to HIV-uninfected individuals, and their implications. Recent Findings In 2017, Johannesburg, South Africa, a life-saving partial liver transplant from an HIV-infected mother to her HIV-uninfected child was performed. This procedure laid the foundation not only for consideration of HIV-infected individuals as living donors, but also for the possibility that HIV-uninfected individuals could receive organs from HIV-infected donors. Recent advances in this field are inclusion of HIV-infected individuals as living organ donors and the possibility of offering HIV-uninfected individuals organs from HIV-infected donors who are well-controlled on combination antiretroviral therapy (cART). The large number of HIV-infected individuals on cART is an unutilised source of otherwise eligible living organ donors. HIV-positive-to-HIV-negative organ transplantation has become a reality, providing possible new therapeutic options to address extreme organ shortages.
引用
收藏
页码:404 / 413
页数:10
相关论文
共 50 条
  • [31] HIV and women's health: Where are we now?
    Tariq, Shema
    Kasadha, Bakita
    WOMENS HEALTH, 2022, 18
  • [32] Induction therapy in heart transplantation: where are we now?
    Aliabadi, Arezu
    Groemmer, Martina
    Cochrane, Adam
    Salameh, Olivia
    Zuckermann, Andreas
    TRANSPLANT INTERNATIONAL, 2013, 26 (07) : 684 - 695
  • [33] HIV and women's health: Where are we now?
    Tariq, Shema
    Kasadha, Bakita
    WOMENS HEALTH, 2022, 18
  • [34] Exosomes and solid cancer therapy: where are we now?
    Zemanek, Tomas
    Danisovic, Lubos
    Nicodemou, Andreas
    MEDICAL ONCOLOGY, 2025, 42 (03)
  • [35] Where are we now? Where are we going? The demographic impact of HIV/AIDS in South Africa
    Williams, BG
    Gouws, E
    Karim, SSA
    SOUTH AFRICAN JOURNAL OF SCIENCE, 2000, 96 (06) : 297 - 300
  • [36] Directions for biomedical research in alcohol and HIV: Where are we now and where can we go?
    Isaki, L
    Kresina, TF
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (13) : 1197 - 1207
  • [37] The time is now: antimicrobial stewardship in solid organ transplantation
    Hand, Jonathan M.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2021, 26 (04) : 405 - 411
  • [38] Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand?
    Delville, Marianne
    Charreau, Beatrice
    Rabant, Marion
    Legendre, Christophe
    Anglicheau, Dany
    HUMAN IMMUNOLOGY, 2016, 77 (11) : 1055 - 1062
  • [39] WHERE WERE WE AND WHERE ARE WE NOW
    VERKADE, JG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1984, 188 (AUG): : 49 - CHED
  • [40] WHERE ARE WE NOW AND WHERE ARE WE GOING
    KARLAN, BY
    GYNECOLOGIC ONCOLOGY, 1995, 59 (03) : 315 - 317